ICAM1 and myeloid sarcoma: Analyzing EEVs from relapsing patients only, CD54+ and CD62E+ phenotypes were present in significantly higher numbers than CD31+ EEVs, indicating that they were more sensitive (in vitro) for identifying MS status (Jimenez et al., 2005).